Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Maccioni RB, Muñoz JP, Barbeito L.

Arch Med Res. 2001 Sep-Oct;32(5):367-81. Review.

PMID:
11578751
3.
4.

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.

Navarrete LP, Pérez P, Morales I, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):678-85. Review.

PMID:
21605038
5.

Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.

Delobel P, Mailliot C, Hamdane M, Sambo AV, Bégard S, Violleau A, Delacourte A, Buée L.

Ann N Y Acad Sci. 2003 Dec;1010:623-34. Review.

PMID:
15033802
6.

Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration.

Sahara N, Maeda S, Takashima A.

Curr Alzheimer Res. 2008 Dec;5(6):591-8. Review.

PMID:
19075586
7.

Tau therapeutic strategies for the treatment of Alzheimer's disease.

Churcher I.

Curr Top Med Chem. 2006;6(6):579-95. Review.

PMID:
16712493
8.

The role of caspase cleavage of tau in Alzheimer disease neuropathology.

Cotman CW, Poon WW, Rissman RA, Blurton-Jones M.

J Neuropathol Exp Neurol. 2005 Feb;64(2):104-12. Review.

PMID:
15751224
9.

Modulation of tau pathology in tau transgenic models.

Brion JP, Ando K, Heraud C, Leroy K.

Biochem Soc Trans. 2010 Aug;38(4):996-1000. doi: 10.1042/BST0380996. Review.

PMID:
20658992

Supplemental Content

Support Center